proDERM
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Kiebitzweg 2, Schenefeld, Schleswig-Hols...Phone Number
+49 408393580Website
www.proderm.deRevenue
$17 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About proDERM
SGS proderm is the globally renowned contract research institute for dermatology. A highly motivated and capable team of over 100 study experts, over 20 medical specialists and over 25 years of experience serve as the basis for competent management of all tasks and studies involving the skin and mucous membrane. This also applies for all products, regardless of regulatory conditions – from cosmetics to medicines. Every year, we test the tolerance and effectiveness of more than 2,000 cosmetic products by renowned manufacturers; we also successfully complete necessary studies for approval of more than five medicines and medical devices. Our ambition? Excellence.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is proDERM your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if proDERM is spiking on competitors!
Product Launch: Get notified when proDERM launches new products
Click to see if proDERM had a recent Job posting/layoffs
Check if proDERM has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on proDERM recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once proDERM has new funding data
Congratulate Masked Content for being promoted to Masked Content at proDERM
proDERM, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at proDERM
Find 3 more new buyers
Company Profile Activity
Activity Insights
proDERM is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
proDERM is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about proDERM.
proDERM Tech Stack
A closer look at the technologies used by proDERM
proDERM News & Media
Follicum AB reports that all patients have completed treatment with FOL-005 in the Phase II study against hair loss
Follicum AB today announced that all patients in the ongoing Phase IIa study with FOL-005 for the treatment of hair loss have completed treatment and made their final visits to the clinic. The study examines the safety and treatment effect of different doses of the drug candidate FOL-005 in just over 200 male patients. Top line results are expected to be presented during spring 2021. The ongoing double-blind and placebo-controlled Phase IIa study examines theAll patients included in Follicum's Phase II study with FOL-005 for stimulation of hair growth
Follicum AB today announced that all patients have been included in the company's ongoing Phase IIa clinical study with its lead drug candidate FOL-005. The study involves more than 200 male patients with hair loss who are being treated with a newly developed topical formulation of FOL-005. No noteworthy adverse reactions have been reported so far and to date none of the patients included have discontinued their participation in the study. The results are expectedMore than 50% of patients enrolled in Follicum's Phase II study of FOL-005 for stimulation of hair growth
Follicum AB ("Follicum" or the "company") today announced that more than 50% of the patients have been recruited in the ongoing, clinical phase IIa study with FOL-005. The study involves 200 male patients with hair loss who are treated daily for four months with a newly developed topical formulation of FOL-005 or placebo. The study is being conducted at the Clinical Research Center for Hair and Skin Science ("CRC") in Berlin, at proDERM in Hamburg
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding proDERM
Sign Up For FreeTo access detailed company insights
SGS proderm is the globally renowned contract research institute for dermatology. A highly motivated and capable team of over 100 study experts, over 20 medical specialists and over 25 years of experience serve as the basis for competent management of all tasks and studies involving the skin and mucous membrane. This also applies for all products,... Read More
